SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950142-17-000220
Filing Date
2017-02-03
Accepted
2017-02-03 16:15:18
Documents
1
Group Members
AISLING CAPITAL III, LPAISLING CAPITAL PARTNERS III LLCAISLING CAPITAL PARTNERS III, LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 eh1700174_13ga2-sunovion.htm SC 13G/A 167064
  Complete submission text file 0000950142-17-000220.txt   168801
Mailing Address 888 Seventh Avenue, 30th Fl New York NY 10106
Business Address 888 Seventh Avenue, 30th Fl New York NY 10106 212-651-6380
AISLING CAPITAL III LP (Filed by) CIK: 0001444717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9
Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449
SUNOVION CNS DEVELOPMENT CANADA ULC (Subject) CIK: 0001532079 (see all company filings)

IRS No.: 981226819 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88902 | Film No.: 17572271
SIC: 2834 Pharmaceutical Preparations